Antiretroviral Therapy Dampens Mucosal Cd4(+) T Lamina Propria Lymphocytes Immune Activation In Long-Term Treated People Living With Hiv-1

HIV infection is characterized by a severe deterioration of an immune cell-mediated response due to a progressive loss of CD4(+) T cells from gastrointestinal tract, with a preferential loss of IL-17 producing Th cells (Th17), a specific CD4(+) T cells subset specialized in maintaining mucosal integrity and antimicrobial inflammatory responses. To address the effectiveness of antiretroviral therapy (ART) in reducing chronic immunological dysfunction and immune activation of intestinal mucosa, we conducted a cross-sectional observational study comparing total IFN-gamma-expressing (Th1) and IL-17-expressing (Th17) frequencies of CD4(+) T lamina propria lymphocytes (LPLs) and their immune activation status between 11 male ART-naive and 11 male long-term ART-treated people living with HIV-1 (PLWH) who underwent colonoscopy and retrograde ileoscopy for biopsies collection. Flow cytometry for surface and intracellular staining was performed. Long-term ART-treated PLWH showed lower levels of CD38(+) and/or HLA-DR+ LPLs compared to ART-naive PLWH. Frequencies of Th1 and Th17 LPLs did not differ between the two groups. Despite ART failing to restore the Th1 and Th17 levels within the gut mucosa, it is effective in increasing overall CD4(+) T LPLs frequencies and reducing mucosal immune activation.